Exscientia plc
DelistedCIK 1865408fmd_0Y6MAHRRWZ5JAKV4D0FSXM72NQManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2019 to Sep 30, 2024, 16 periods
Exscientia plc financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2023 | FY2022 | Change | Source |
|---|---|---|---|---|
| Cash from operating activities | -£117.6 million | -£60.5 million | 20-F 2024-03-21 · proof | |
| Free cash flow | -£144.1 million | -£82.9 million | 20-F 2024-03-21 · proof |
- What was Exscientia plc's cash from operating activities in fiscal 2023?
- Exscientia plc reported cash from operating activities of -£117.6 million for fiscal 2023 (the year ended Dec 31, 2023), against -£60.5 million the year before. Source: the 20-F filed with the SEC on Mar 21, 2024. SEC
- What was Exscientia plc's free cash flow in fiscal 2023?
- Exscientia plc reported free cash flow of -£144.1 million for fiscal 2023 (the year ended Dec 31, 2023), against -£82.9 million the year before. Source: the 20-F filed with the SEC on Mar 21, 2024. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1865408&period_type=annual&limit=5"Information only, not investment advice.